AKT1 and neoplasm: By investigating the transcriptional changes in HB tumor cells on CM-272 exposure, we have detected transcriptional downregulation of the survival factor IGF2 and subsequently reduced activity of PI3K-AKT signaling as the main target of the dual inhibition of UHRF1-driven consequences.